Detailed medication manual for baricitinib (OLUMIANT) in the treatment of patients with rheumatoid arthritis

Baricitinib (trade name: Alemin/OLUMIANT) is a prescription drug designed for adult patients with moderately to severely active rheumatoid arthritis, especially those who have poor response or intolerance to traditional disease-modifying antirheumatic drugs (DMARDs). The following is a detailed dosing manual for baricitinib, designed to help patients better understand how to use the drug.

1. Medication uses and methods of administration

Baricitinib is mainly used to relieve the symptoms of moderately to severely active rheumatoid arthritis. It is recommended that patients take it once daily, with a dose of 2mg each time, which can be administered orally. Whether it is taken with a meal or on an empty stomach, it will not affect its efficacy. Patients can flexibly arrange their medication time according to their personal habits.

2. Medication Safety Instructions

1. Professional guidance: The use of baricitinib should be under the guidance of doctors with experience in the diagnosis and treatment of rheumatoid arthritis.

2. Regular monitoring: During the period of medication, patients should regularly undergo routine blood tests, liver function, blood lipids and other indicators, and pay attention to the emergence of infection symptoms.

3. Allergy contraindications: Patients who are allergic to baricitinib or its components should avoid use.

4. Drug Interactions: Be sure to tell your doctor about all the drugs you are taking, including prescription drugs, over-the-counter drugs, and supplements, to prevent potential drug interactions.

3. Coping with Adverse Reactions

Possible adverse reactions to baricitinib include upper respiratory tract infection, nausea, and herpes zoster. If patients experience adverse reactions such as serious infection, elevated liver transaminases, or blood problems (such as anemia, thrombocytopenia), they should seek medical attention immediately and inform the doctor that they are using baricitinib.

4. Storage and carrying of medicines

Store baricitinib in a dry environment at room temperature, away from direct sunlight. When carrying medicines, make sure their packaging is intact and avoid exposure to moisture and high temperatures.

5. Price and medical insurance information

Currently, the price of the original drug baricitinib is about more than one thousand yuan per box, and the specification is2mg*28 tablets. Qualified patients can also enjoy medical insurance reimbursement policies, thereby reducing their financial burden.

In summary, baricitinib is an effective treatment for rheumatoid arthritis. Before use, patients should fully understand its indications, usage and dosage, and precautions, and use it rationally under the guidance of a doctor. At the same time, patients should pay close attention to physical reactions and seek medical treatment in time to deal with possible adverse reactions to ensure the safety and effectiveness of the medication.